Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging

Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study

“…However, the sample size was calculated based on a power analysis to detect clinically valid correlation, which was successfully established in our study. Second, although we recruited patients clinically diagnosed with NAFLD, ~25% (five patients) of these participants showed PDFF generally regarded as none to minimally steatotic (≤5%) . However, with the given purpose to evaluate linearity, bias, and precision of QIB, it is beneficial to include the entire range of measurement.…”

“…Second, although we recruited patients clinically diagnosed with NAFLD,~25% (five patients) of these participants showed PDFF generally regarded as none to minimally steatotic (≤5%). 8,39 However, with the given purpose to evaluate linearity, bias, and precision of QIB, it is beneficial to include the entire range of measurement. We were also able to elaborate on a higher CV among patients with a lower range of PDFF.…”

Quantitative analysis of hepatic iron in patients suspected of coexisting iron overload and steatosis using multi‐echo single‐voxel magnetic resonance spectroscopy: Comparison with fat‐saturated multi‐echo gradient echo sequence

“…There have been some studies focused on simultaneous R Ã 2 and fat evaluation. 9,14,[35][36][37] The major advantage of GRE-based sequences, especially those using a 3D acquisition, over SVS is that simultaneous fat and iron quantification can be performed for the whole liver in one breathhold, in a clinical setting. However, separating the fat and water signal contributions may be challenging with iron overload.…”

Vergleich einer kommerziell erhältlichen, Formula-basierten, mit Haferballaststoffen angereicherten Ernährungstherapie mit einer isokalorischen diätetischen Therapie ohne Formula zur Therapie der nicht-alkoholischen Fettlebererkrankung (NAFLD) – eine randomisierte, kontrollierte Interventionsstudie

“…Die NAFLD ist mit Insulinresistenz assoziiert und tritt meist zusammen mit Adipositas auf; sie wird daher auch als hepatische Manifestation des metabolischen Syndroms bezeichnet [2]. Durch die hohe Adipositas-Prävalenz weltweit ist das Vorkommen der NAFLD in den letzten Jahrzehnten erheblich angestiegen und liegt in der deutschen Bevölkerung aktuell bei 42,2 % [3,4].…”